Five path labs strike a diagnostic alliance

“Neuberg Diagnostics, named after modern biochemistry pioneer Carl Neuberg, has been formed by five leading pathology labs from four nations to provide affordable diagnostics to the people the world over,” healthcare entrepreneur and its founder GSK Velu told reporters, unveiling the consortium here. 

This is an alliance of laboratories such as Anand Diagnostic Laboratory (Karnataka), Supratech Micropath (Gujarat), Ehrlich Laboratory (Tamil Nadu) in India, Global Labs (South Africa) and Minerva Labs (UAE). Neuberg will have three reference laboratories located in Bengaluru and Ahmedabad in India and Durban in South Africa for tests using in-vitro diagnostics techniques, lab automation, big data analytic tools and laboratory information system. Union Minister of State for Health and Family Welfare Anupriya Patel, Sri Lankan Health, Nutrition and Indigenous Medicine Minister Rajitha Senaratne, UAE’s Dubai Health Authority Medical Director Awatif Juma-al Bahar and South Africa’s University of KwaZulu-Natal Pro-Vice-Chancellor Salim S Abdool Karim were present on the occasion. 

“The consortium will be a platform to introduce new generation pathology services and provide healthcare at affordable cost,” Patel said. “We will implement best practices, adopt new technology and convert research into innovation to benefit medical community and improve patient care,” said Anand K of Anand Diagnostic Laboratory. 

“The alliance will strengthen our relationship with India. Leveraging the expertise of pathology brands, we look forward to levelling the gaps in our healthcare system,” said Sri Lanka’s Ministry of Health official Hemantha Beneragama. The new entity is projected to have a collective annual revenue of Rs 400 crore. Neuberg will also provide services in genomics (study of genomes) and proteomics (study of proteins) to doctors and patients alike. The consortium will pool in advanced diagnostics technology and perform about 5,000 pathological tests, promoting prevention and early diagnosis, thereby empowering the Indian healthcare consumer. Neuberg will also combine conventional pathology testing, new gen laboratory techniques for enhanced patient outcomes.